At this point, the anti-proliferative effects of endogenous CB1R and CB2R agonists in different tumor cell lines have been attributed to the increase in the sphingolipid ceramide and the subsequent activation of deadly cascades [4]. This evidence concerns the gene CNR1 and neoplasm.